Zambia and US Revise Contested Health Aid Deal

Zambia has signed a five-year, $1.5 billion health financing agreement with the United States after negotiators removed controversial provisions concerning the sharing of biological specimens and patient data. The Zambian government also says the health deal is separate from negotiations over the country’s mineral resources; those discussions will take place independently. Talks had stalled earlier in the year amid concerns in Lusaka about privacy and an alleged US effort to link health funding with access to critical minerals. Health Minister Roma Chilengi said the information Zambia shares will be limited to what is needed to monitor and evaluate US-funded health programmes. Funding from the two countries is reportedly expected to total $3.6 billion over the agreement’s five-year term. The article also notes that Washington said in 2025 it was withdrawing $50 million in annual health aid to Zambia, citing what it called “systemic theft” of donated medicines and supplies. The agreement is part of the Trump administration’s effort to establish bilateral health arrangements with African countries following the dismantling of the US Agency for International Development. Under the approach described, African governments would gradually increase their own health spending as US assistance is phased out. Ghana and Zimbabwe have rejected agreements over data-sharing demands, while at least nine other African countries have accepted the condition. The US says health data and specimens could be provided to as many as 10 American non-government entities for the development of diagnostics and medical treatments. The deal thus reflects a wider debate about health financing, data privacy, access to biological materials, and the terms of US assistance in Africa.

Zambia has signed a five-year health financing agreement with the United States after months of public controversy over data privacy and whether aid was linked to access to the country’s mineral resources. The memorandum, signed in Lusaka alongside a data-sharing agreement, provides about $1.5 billion in US funding, with Zambia also contributing. Officials say the revised terms address concerns about privacy, intellectual property and benefit-sharing. Health Minister Roma Chilengi said requirements to send biological specimens to the US had been removed, individual patient records would not be shared, and information exchanges would be limited to data needed to assess programmes funded by the deal. The dispute began after a draft agreement was leaked. Civil society groups and HIV advocates warned that its terms could enable extensive, potentially long-term access to health data and specimens, and criticized what they viewed as one-way information sharing. Activists and opposition figures also raised concerns that the funding was connected to preferential access for US companies to Zambia’s copper and other critical minerals. Former Foreign Minister Mulambo Haimbe called the data terms a violation of privacy and accused Washington of tying aid to minerals; then-US ambassador Michael Gonzales denied the allegation. The controversy was compounded by a US suspension of drug funding following an embassy allegation of theft of donated medicines, which Zambia disputed. The agreement follows the closure of USAID, ordered by President Donald Trump, and a wider US effort to make African governments share more of the cost of health programmes. Kenya, Tanzania and Uganda have signed similar arrangements, while Ghana and Zimbabwe have rejected agreements over data and specimen-sharing conditions. The Zambia package is intended to support HIV/AIDS, tuberculosis, malaria, maternal and child health, disease surveillance and broader health-system work, including recruiting community health workers. The US says its contribution will decline over five years as Zambia increases domestic spending; officials estimate the combined 2026–2030 package at roughly $3.6 billion, although estimates of Zambia’s share have varied. The article also notes criticism that USAID cuts have weakened health programmes and may have slowed detection and response to the Ebola outbreak in the Democratic Republic of Congo. The US disputes that assessment, says its new approach is more aligned and effective, and points to $270 million donated to combat the epidemic.

The Washington Post reports that the Trump administration withdrew or revised several controversial provisions that had appeared in early versions of a billion-dollar health agreement with Zambia. According to the article’s opening, the final agreement’s text was reviewed by the newspaper, and people familiar with the negotiations also described the changes. One provision in the earlier draft would have sought greater U.S. access to Zambia’s critical mineral reserves. The headline indicates that demands related to data were also scaled back, though the supplied article text does not explain what data was at issue or how the final terms changed. The excerpt presents the revisions as the result of negotiations and distinguishes between the initial proposals and the final agreement. It does not provide details about the health programs covered, the specific mineral provisions, the data terms, the timing or participants in the negotiations, or the responses of Zambian officials. Because only the headline and opening sentence were provided, those topics cannot be described reliably here. The article is attributed to Adam Taylor and published by The Washington Post. Overall, the available material focuses on the U.S. government’s retreat from contested provisions in a major bilateral health deal, especially a proposed U.S. role in accessing Zambia’s mineral reserves. The headline adds that data-related demands were part of the backtracking, but the excerpt offers no further explanation. This summary is therefore limited to claims expressly contained in the supplied text and does not infer the agreement’s broader consequences or the reasons for the changes.